Press release
Sales of Erectile Dysfunction (ED) Drugs Market in 2022-2031
Erectile Dysfunction (ED) Drugs Market: IntroductionAccording to the report, the global erectile dysfunction drugs market was valued at US$ 3.4 Bn in 2017 and is projected to contract at a CAGR of -3.1% from 2021 to 2028. Oral phosphodiesterase type 5 inhibitors are one of the most commonly used erectile dysfunction drugs across the globe. sildenafil citrate and other PDE 5 inhibitors such as tadalafil and Levitra/Staxyn (vardenafil) are the most consumed drugs for ED treatment across the world. On losing patent and marketing exclusivity, these drugs will become available in the public domain in the form of low cost generics.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1550
The loss of patent exclusivity of a branded drug results in revenue reduction by around 40% in the first year, which goes on decreasing to 30% and 20% in the following years. This can be attributed to generic equivalents of these drugs are manufactured and marketed at 1/10th of the price of the original branded drug, thereby resulting in much higher consumption of the drugs since efficacy and demand remains high. Consequently, the generics segment is anticipated to be a promising investment area even for original molecule manufacturers, since it is a mode of sustenance and offsetting expenditure.
Pfizer also plans to market it in other countries in the developing world. Bayer AG introduced the orally disintegrating tablet for its Levitra (vardenafil) drug in Germany, France, Austria, Hungary, Spain, Sweden, Poland, Denmark, and Britain, in March 2011.
Furthermore, Asia Pacific and Rest of the World are favorable regions for generic companies to initiate, establish, and expand business due to fewer entry barriers and shorter legal hurdles. Large populations, availability of raw materials, and cheaper workforce have enhanced the manufacturing capabilities of these companies.
Read Report Overview- https://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html
The global erectile dysfunction drugs market is set to experience a patent cliff toward the end of the forecast period. The market is highly genericized through 2019 all over due to patent expiration in these countries. However, it still consists of blockbuster drugs such as sildenafil citrate, tadalafil and Levitra/Staxyn (vardenafil) in the U.S. that has been driving the market in the past few years. tadalafil and Levitra/Staxyn (vardenafil) are set to lose marketing and patent exclusivity in 2017 and 2018, respectively, while sildenafil citrate is scheduled to expire in the U.S. by October 2020. This event is expected to have a profound effect on the overall market for erectile dysfunction drugs, causing a drastic dip in market revenue by the end of the forecast period. Moreover, approved ANDAs for these molecules will lead to intense generic competition.
Increase in Incidence of Various Diseases and Sedentary Lifestyles
The number of patients suffering from diabetes mellitus, hypertension, hypercholesterolemia, spinal cord injuries, cardiovascular diseases, and various other conditions is rising globally. Increase in incidence rates of diseases and their associated drug treatments affect the normal functioning of in men, thereby contributing to the rise in demand for erectile dysfunction drugs. For instance, chlorthalidone, propanolol, diazepam, cimetidine, and naproxen are some of the drugs that could cause ED. These drugs could help in treating a particular disease condition; however, these can also cause hormonal imbalance, affect nerves, and blood circulation, thereby increasing the risk of ED in men.
Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=1550
According to the United Nations Economic and Social Commission for Asia and the Pacific, around 60% of the world's geriatric population lives in Asia Pacific. The number of elderly people is estimated to double from 547 million in 2016 to 1.3 billion by 2050. Hence, increase in use of such drugs to treat the above mentioned disease conditions will continue to encourage the use of erectile dysfunction drugs, thereby driving the market.
Moreover, obesity has been linked to increased risk of erectile dysfunction. Sedentary lifestyle and increase in incidence of obesity are expected to boost the ED market in the long term. Smoking and alcoholism have both been shown to increase the risk of ED.
Development of New Formulations to Drive Global Market
Localized drug delivery techniques for erectile dysfunction treatment such as the use of creams and pellets that show better efficacy and performance will be frequently sought after by medical professionals and facilities who have been dogged by severe shortcomings of current drugs. Successful observations of combination therapy have been encouraging and market leaders should focus on combination molecules such as PDE 5 inhibitors to gain a significant advantage due to several benefits such as lower drug doses and reduced incidence of adverse effects.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1550
Segment to Dominate Market
In terms of drug, the global erectile dysfunction drugs market has been classified into Staxyn/Levitra, Stendra/Spedra, and others. The others segment includes Zydena , Mvix, Helleva, Vitaros, Caverject Impulse, generic products, and pipeline products. tadalafil sales exceeded that of sildenafil citrate due to patent expiration of sildenafil citrate in major countries in Europe. Entry of generic competition into these markets following the loss of exclusivity will cause a rapid and severe decline in revenue for the product. tadalafil and Adcirca (tadalafil) went off patent in major markets in Europe and the U.S. in November 2020.
Enquiry Before Buying @
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1550
North America to Dominate Global Market
In terms of region, the global erectile dysfunction (ED) drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global erectile dysfunction (ED) drugs market in 2020, followed by Asia Pacific. High prevalence and increase in incidence of erectile dysfunction in the U.S. and Canada and high adoption of branded treatment for ED ca be attributed to the U.S.'s market dominance. However, decrease in healthcare cost and decrease in hospitalization rates are likely to restrain the market in North America during the forecast period.
Competition Landscape
The global erectile dysfunction (ED) drugs market is fragmented in terms of number of players. Key players in the global market include Pfizer, Inc., Dong-A ST Co., Ltd., Eli Lilly and Company, Bayer AG, Vivus, Inc., and Teva Pharmaceutical Industries Ltd. Manufacturers are launching new products in the international market to tap the unmet needs of erectile dysfunction. Other prominent players operating in the global market include SK Chemicals, Meda Pharmaceuticals, Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda., Apricus Biosciences, Inc., and Futura Medical plc.
Contact
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sales of Erectile Dysfunction (ED) Drugs Market in 2022-2031 here
News-ID: 2785895 • Views: …
More Releases from Transparency Market Research
Europe Anti-slip Paper Market Valuation Set to Reach USD 450.1 Million by 2035, …
The Europe Anti-slip Paper Market is poised for robust growth over the forecast period, driven by rising demand for sustainable, efficient, and safe packaging solutions across industries. Valued at US$ 214.4 Mn in 2024, the market is projected to almost double and touch US$ 450.1 Mn by 2035, registering a CAGR of 7.0% from 2025 to 2035. This growth is supported by stringent regulatory frameworks, the rapid expansion of e-Commerce,…
Ethyl Acetate Market Outlook 2035: Global Valuation to Reach USD 15.1 Billion Am …
The global ethyl acetate market is entering a phase of sustained expansion driven by strong industrial demand and accelerating adoption of green, sustainable solvents. Valued at US$ 6.5 Bn in 2024, the market is projected to expand at a CAGR of 8.0% from 2025 to 2035, ultimately reaching US$ 15.1 Bn by 2035. This growth reflects rising use across paints and coatings, adhesives, pharmaceuticals, packaging, and the food & beverage…
HPLC Column Market Outlook 2035: Global Industry to Reach USD 4.7 Billion by 203 …
The global HPLC Column Market is poised for steady and sustained growth through 2035, supported by rising demand for analytical testing across pharmaceutical, biotechnology, food and beverages, and environmental sectors. Valued at US$ 2.6 Bn in 2024, the industry is projected to reach US$ 4.7 Bn by 2035, expanding at a CAGR of 5.3% from 2025 to 2035. Increasing regulatory compliance, technological advancements in column design, and growing applications in…
Carboxylic Acid Market Outlook 2035: Global Market to Reach USD 12.9 Billion by …
The global carboxylic acid market continues to gain momentum as demand surges across diverse industrial applications. Valued at US$ 6.6 Bn in 2024, the market is projected to expand at a CAGR of 6.3% between 2025 and 2035, ultimately reaching US$ 12.9 Bn by 2035. This strong growth trajectory is driven by the rising consumption of carboxylic acids in chemicals, food and beverages, pharmaceuticals, agriculture, personal care, and industrial manufacturing.…
More Releases for Levitra
Vardenafil (Levitra) Manufacturing Plant Project Report 2023: Industry Trends, P …
IMARC Group's report titled "Vardenafil (Levitra) Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing an vardenafil manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more.
In addition to the…
Erectile Dysfunction Drugs Market Contains a Qualified and Comprehensive Analysi …
Erectile dysfunction Drugs Market is the inability to attain or maintain penile erection in men, sufficient for successful sexual intercourse. It is also known as impotence. It is a common medical disorder primarily affecting men older than 40 years of age. Growing elderly population, increasing awareness and patient education, elevated inclination towards a sedentary lifestyle, and growing incidence of several genitourinary diseases are some of the factors expected to drive…
Insight on the Growth of Erectile Dysfunction Drugs Market Growth with Challenge …
Summary:
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The rising technology and developments taking place in the Erectile Dysfunction Drugs market is also depicted in this research report. Factors that are boosting the growth of…
Erectile Dysfunction Drugs Market 2018 By Products Viagra, Cialis, Levitra, Sten …
Worldwide Recent Trend “Erectile Dysfunction Drugs Market” Research Report Available to MarketResearchFuture.com The Market of Erectile Dysfunction Drugs is Driven by the Number of Drugs Available in the Market and Increasing Number of Men Suffering from this Disorder Available.
Global Erectile Dysfunction Drugs Market - Scenario
Inability to keep firm erection firm enough during sexual intercourse in known as erectile dysfunction. It is also known as impotence. It is a common medical…
Global Erectile Dysfunction Market, By Product (Viagra (Sildenafil citrate), Cia …
Erectile dysfunction was earlier believed to be a condition mainly prevalent among elderly men. However, a recent study conducted by medical institution across the globe, explains that the erectile dysfunction also affects younger men, due to sex hormone imbalance at the early stage of their puberty. There are many medications available to treat erectile dysfunction that are especially effective among young men, as they are can easily absorb the drugs…
Research Delivers Insight into Erectile Dysfunction Drugs Market
Transparency Market Research presents this most up-to-date research on "Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019"
Erectile dysfunction (ED) is the inability to achieve or maintain satisfactory erection of penis during sexual intercourse. It is usually an age related condition but can also be triggered by psychological factors. It may occur due…
